A Clinical Study in Healthy Subjects Which Aims to Investigate the Safety, the Tolerability and the Effects of GRT0151Y and How the Compound is Taken up and Excreted From the Body
Clinical trial NCT03761407 · COMPLETED
Trial details
- NCT number
- NCT03761407
- Sponsor
- Grünenthal GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-30
- Primary completion
- 2005-07-26
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.